177 related articles for article (PubMed ID: 31287204)
1. Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.
Keerthy HK; Mohan S; Basappa ; Bharathkumar H; Rangappa S; Svensson F; Bender A; Mohan CD; Rangappa KS; Bhatnagar R
Chem Biodivers; 2019 Sep; 16(9):e1900234. PubMed ID: 31287204
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
Grewal AS; Lather V; Pandita D; Dalal R
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors.
Almatary AM; Elmorsy MA; El Husseiny WM; Selim KB; El-Sayed MA
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700403. PubMed ID: 29573453
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells.
Liu J; Ye W; Xu JP; Wang HT; Li XF; Wang WY; Zhou ZZ
Eur J Med Chem; 2021 Nov; 224():113700. PubMed ID: 34311158
[TBL] [Abstract][Full Text] [Related]
7. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
8. Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.
Sahin Z; Biltekin SN; Yurttas L; Berk B; Özhan Y; Sipahi H; Gao ZG; Jacobson KA; Demirayak Ş
Eur J Med Chem; 2021 Feb; 212():113125. PubMed ID: 33422981
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.
El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent.
Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P
Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361
[TBL] [Abstract][Full Text] [Related]
12. Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
Ram Reddy T; Rajeshwar Reddy G; Srinivasula Reddy L; Jammula S; Lingappa Y; Kapavarapu R; Meda CL; Parsa KV; Pal M
Eur J Med Chem; 2012 Feb; 48():265-74. PubMed ID: 22217868
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F
Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment.
Zhang R; Li H; Zhang X; Li J; Su H; Lu Q; Dong G; Dou H; Fan C; Gu Z; Mu Q; Tang W; Xu Y; Liu H
Eur J Med Chem; 2021 Feb; 211():113004. PubMed ID: 33218684
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S
Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945
[TBL] [Abstract][Full Text] [Related]
16. Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.
Kato Y; Kawasaki M; Nigo T; Nakamura S; Fusano A; Teranishi Y; Ito MN; Sumiyoshi T
Bioorg Med Chem; 2013 Sep; 21(18):5851-4. PubMed ID: 23910988
[TBL] [Abstract][Full Text] [Related]
17. Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors.
Kawasaki M; Fusano A; Nigo T; Nakamura S; Ito MN; Teranishi Y; Matsumoto S; Toda H; Nomura N; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jun; 24(12):2689-92. PubMed ID: 24794103
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
